Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic ... in doing so -- unearthed a potential new ... Early Diagnosis and Monitoring of Lupus Nephritis -- On Your Smartphon ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Natural treatments for lupus are often used alongside conventional medical treatment. They may be used to help reduce symptoms, which can include fatigue, joint pain, and hair loss. Lupus is an ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.